Innovasis Signs Private-Label Agreement with Stability Biologics

Innovasis expanded their orthobiologics footprint, signing a private-label agreement with Stability Biologics, an FDA-registered tissue processing and distribution center that includes Physio® bone allograft. The private-labeled products are slated for launch by year-end.

Innovasive supplies spinal hardware and allograft tissue such as DBM and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us